查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439962

全球吻合装置市场：洞察、竞争格局、市场预测：2030 年

Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

在 2024 年至 2030 年的预测期内，全球吻合器材市场规模预计将以 5.3% 的复合年增长率扩大。 吻合装置市场正在出现显着的市场成长，这主要是由于冠状动脉绕道手术（CABG）和迴肠造口术的增加。 此外，冠状动脉疾病、胃病和慢性肾病的盛行率不断上升，设备技术不断进步，老年患者负担迅速增加，以及产品上市和批准数量不断增加，都推动了市场对吻合设备的需求。它产生性。

影响吻合装置市场成长的主要因素之一是全球冠心病患病率的上升。 根据美国疾病管制与预防中心（CDC）发布的2023年数据，冠状动脉心臟病是美国最常见的心臟病类型，2020年导致382,820人死亡。 减少心血管疾病的关键在于纳入心血管疾病管理干预措施，这些干预措施可以透过各种外科手术（包括吻合装置）进行。 因此，冠状动脉疾病病例的增加预计将增加手术后需要吻合器来封闭血管和动脉的手术数量，并最终增加吻合器在心血管手术中的使用。

此外，动脉粥状硬化盛行率的增加也可能增加市场对吻合器械的需求。 动脉粥状硬化是由动脉壁内斑块的堆积引起的，必须透过手术去除。 在动脉硬化治疗的情况下，可能需要吻合装置来连接两条动脉，因此外科手术的增加将增加对吻合装置的需求。

本报告调查了全球吻合装置市场，并提供了市场概述，包括按产品、用途、应用、最终用户、地区以及参与市场的公司概况划分的趋势。

目录

第1章吻合器械市场报告简介

第2章吻合装置市场执行摘要

第3章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章吻合器市场主要因素分析

  • 推动吻合装置市场的因素
  • 吻合器材市场的抑制因素与挑战
  • 吻合装置市场机遇

第5章波特对吻合器材市场的五力分析

第6章COVID-19对吻合器材市场的影响分析

第7章吻合器市场概况

  • 按产品
  • 透过易用性
  • 依用途
  • 按最终用户
  • 按地区

第8章吻合装置市场公司与产品概况

  • Intuitive Surgical
  • B. Braun SE
  • BAXTER
  • CryoLife, Inc
  • JOHNSON & JOHNSON
  • Medtronic
  • Sinolinks Medical Innovation, Inc.
  • microcuremed
  • BIOWIN PHARMACEUTICAL CO., LIMITED
  • Waston Medical Corporation
  • W. L. Gore & Associates, Inc.
  • Hangzhou Demo Medical Technology Co., Ltd
  • BD.
  • Dolphin Sutures
  • gpcmedical
  • Golden Stapler Surgical Co., Ltd.
  • JIANGSU JOYMED TECH CO., LTD
  • Changzhou Haiers Medical Devices Co., Ltd
  • Shanghai MedEco Industry Co., Ltd
  • ChangZhou WeiPu Medical Devices CO., LTD

第9章KOL浏览量

第 10 章专案方法

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0643

Anastomosis Device Market By Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, And Surgical Adhesives), By Usability (Disposable And Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, And Others), By End-User (Hospitals & Clinics, Ambulatory Care Centres, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular, gastrointestinal disease, & chronic kidney diseases and the increasing technological advancements in the device

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030. The anastomosis device market is observing remarkable market growth primarily due to the increasing number of coronary bypass graft surgery (CABG) and Ileocolic anastomosis. Further, the rising prevalence of coronary disease, gastric disease, and chronic kidney disease, the increasing technological advancements in the device, the up-surging burden of elderly patients, the increasing product launches, approvals, and others will create a necessity for the anastomosis device in the market. Therefore, the market for anastomosis devices is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Anastomosis Device Market Dynamics:

One of the key factors influencing the growth of the anastomosis device in the market is the increasing prevalence of coronary heart disease across the world. According to 2023 data published by the Centers for Disease and Prevention Control (CDC), coronary heart disease is the most common type of heart disease in the US and accounted for 382,820 deaths in 2020. The key to cardiovascular disease reduction lies in the inclusion of cardiovascular disease management interventions which can be done through various surgical procedures that may involve anastomosis devices. Thus, the increasing cases of coronary heart disease will increase the number of surgical procedures which may require anastomosis devices for sealing the vessel and arteries after the surgery, ultimately increasing the use of anastomosis in cardiovascular surgery.

Further, the increasing prevalence of atherosclerosis can also increase the demand for anastomosis devices in the market. Atherosclerosis is caused by a build-up of plaque in the inner lining of an artery wall, which needs removal through surgery. The surgery may need an anastomosis device for joining both arteries in case of arteriosclerosis treatment, thus the increasing number of surgical procedures will increase the demand for anastomosis devices.

Elderly patients are more prone to various chronic diseases such as chronic kidney diseases, coronary vascular diseases, obesity, atherosclerosis, and others. For instance, the latest study conducted by Heart Research Institute concluded that over the age of 40, people in general good health have about a 50% chance of developing serious atherosclerosis, with this risk increasing with age. Most people over the age of 60 have some atherosclerosis and need surgery for removing plaque. Thus after atherosclerosis managing surgical procedure, vessels need a connection that can be made by sealants or staplers, ultimately increasing the demand for anastomosis devices.

According to the American Cancer Society 2020-2022, an estimated 104,610 new cases of colon cancer and 43,340 cases of rectal cancer were diagnosed in the US in 2020. Colon cancer may need surgery for treatment which further may need an anastomosis device for connecting the leftover vessel part of the colon to each other. Thus, the increasing prevalence of colon cancer will increase the surgical number which treats colon cancer, thereby increasing the demand for anastomosis devices.

Therefore, the factors stated above collectively will drive the overall anastomosis device market during the forecast period from 2024-2030.

However, the complications due to anastomosis, the increasing demand for minimally invasive or non-invasive treatment approaches, and others may prove to be challenging factors for anastomosis device market growth.

The anastomosis device market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitalizations and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, stroke, and others. This resulted in a reduced number of patients in hospitals or surgical centers. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of treatment devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normal life in the economic landscape initiated the process of resumption of regular healthcare services such as patient visits and surgeries for the treatment of aforementioned ailments, thereby bringing the demand for anastomosis devices on track.

Anastomosis Device Market Segment Analysis:

Anastomosis device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Ambulatory Care Centers, Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the anastomosis device market, the surgical staplers segment is expected to have a revenue share of XX in the year 2023. This was primarily owing to the rising focus of manufacturers towards developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals of the anastomosis device will aid in increasing its demand in the market. For instance, in March 2022, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.

North America is expected to dominate the overall Anastomosis Device Market:

Among all the regions, North America is expected to hold the largest share of the anastomosis device market in 2022 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the growing government initiatives to raise effective management of coronary bypass graft surgery, the rising demand for fistula for dialysis treatment, the expanding burden of elderly patients prone to various cardiovascular disorders, the increasing prevalence of kidney diseases, increasing product launches, and the presence of advanced healthcare facilities in the region, which will boost the anastomosis market in North America during the forecast period.

For instance, as per the Centre for Disease and Prevention Control (CDC), in 2022, 20.1 million Americans aged 20 years and older were affected by coronary heart disease (CHD) 2020. Additionally, as per the same source, every year nearly about 805,000 Americans experience a heart attack. This figure of heart attack can be controlled by providing proper treatment for CHD. The treatment of CHD will need surgery in which two vessels or arteries might be requiring a closure which can be done by an anastomosis device. Thus, the increasing prevalence of CHD in the country will increase the number of surgical procedures, thereby increasing the demand for anastomosis devices in the region.

According to the United States Renal Data System 2020 Annual Data Report, nearly 786,000 people in the United States were living with end-stage renal disease (ESRD) and 71% of them were on dialysis. Dialysis patients need vascular access for dialysis therapy, this vascular access is made by the connection of artery and vein, which is called arteriovenous anastomosis. This procedure is primarily done by anastomosis devices. Thus, the increasing number of dialysis procedures will increase the number of arteriovenous anastomoses, ultimately increasing the demand for anastomosis devices. Thus, the increasing prevalence of chronic kidney disease will also increase the market for anastomosis disease in the North America region.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the anastomosis device market.

Anastomosis Device Market Key Players:

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Device Market:

In February 2022, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

In March 2022, Johnson & Johnson launched the ECHELON Stapler which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.

In April 2022, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.

In December 2020, Medtronic Private Limited announced the launch of the EEA(TM) Circular Stapler with Tri-Staple(TM) Technology. The device has three rows of varied height staples to deliver 30 percent more security to the staple line and requires 60 percent lesser firing force in the operating room as compared to current devices.

Key Takeaways from the Anastomosis Device Market Report Study

Market size analysis for current anastomosis device market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the anastomosis device market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global anastomosis device market.

Various opportunities are available for the other competitor in the anastomosis device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current anastomosis device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for anastomosis device market growth in the coming future?

Target Audience who can be benefited from this Anastomosis Device Market Report Study

Anastomosis devise products providers

Research organizations and consulting companies

Anastomosis device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in anastomosis device

Various end users who want to know more about the anastomosis device market and the latest technological developments in the anastomosis device market.

Frequently Asked Questions for the Anastomosis Device Market:

1. What is an anastomosis device?

The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.

2. What is the global market for anastomosis devices?

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030.

3. What are the drivers for the global anastomosis device market?

The anastomosis device market is witnessing positive market growth owing to the factors such as the rising prevalence of coronary artery disease, arteriosclerosis, and chronic kidney disease, the growing burden of the elderly population, the increasing product launches and approvals, the presence of key players in the market, and others will create an exigency for the anastomosis device market.

4. Who are the key players operating in the global anastomosis device market?

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

5. Which region has the highest share in the anastomosis device market?

Among all the regions, North America is estimated to amass a significant revenue share in the global anastomosis device market. This can be ascribed to the growing cases of coronary bypass graft surgery, the rising burden of elderly patients, the increasing prevalence of chronic kidney disease, the presence of advanced healthcare facilities in the region, and others that act as a supportive factor for the North America anastomosis device market growth.

Table of Contents

1.Anastomosis Device Market Report Introduction

2. Anastomosis Device Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Anastomosis Device Market Key Factors Analysis

  • 4.1. Anastomosis Device Market Drivers
    • 4.1.1. Rising number of surgical procedures owing to the prevalence of coronary artery disease, arteriosclerosis, and other diseases
    • 4.1.2. Rising cases of dialysis which need arteriovenous fistula
    • 4.1.3. Availability of technologically advanced products in the market
  • 4.2. Anastomosis Device Market Restraints and Challenges
    • 4.2.1. Complications due to anastomosis
    • 4.2.2. Increasing demand for the minimally invasive or non-invasive treatment approach
  • 4.3. Anastomosis Device Market Opportunities
    • 4.3.1. Incorporation of automatic anastomosis devices such as robotic surgical staplers and others

5. Anastomosis Device Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Anastomosis Device Market

7. Anastomosis Device Market Layout

  • 7.1. By Product
    • 7.1.1. Surgical Staplers
    • 7.1.2. Surgical Sutures
    • 7.1.3. Surgical Sealants
    • 7.1.4. Surgical Adhesives
  • 7.2. By Usability
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By Application
    • 7.3.1. Cardiovascular surgery
    • 7.3.2. Gastrointestinal surgery
    • 7.3.3. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & clinics
    • 7.4.2. Ambulatory surgical centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.1.1. United States Anastomosis Device Market in USD million (2021-2030)
      • 7.5.1.2. Canada Anastomosis Device Market in USD million (2021-2030)
      • 7.5.1.3. Mexico Anastomosis Device Market in USD million (2021-2030)
    • 7.5.2. Europe Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.2.1. France Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.2. Germany Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.4. Italy Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.5. Spain Anastomosis Device Market in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Anastomosis Device Market in USD million (2021-2030)
    • 7.5.3. Asia-Pacific Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.3.1. China Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.2. Japan Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.3. India Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.4. Australia Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.5. South Korea Anastomosis Device Market in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia Pacific Anastomosis Device Market in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW) Anastomosis Device Market Size in USD million (2021-2030)
      • 7.5.4.1. Middle East Anastomosis Device Market in USD million (2021-2030)
      • 7.5.4.2. Africa Anastomosis Device Market in USD million (2021-2030)
      • 7.5.4.3. South America Anastomosis Device Market in USD million (2021-2030)

8. Anastomosis Device Market Company and Product Profiles

  • 8.1. Intuitive Surgical
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. B. Braun SE
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. BAXTER
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. CryoLife, Inc
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. JOHNSON & JOHNSON
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Sinolinks Medical Innovation, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. microcuremed
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. BIOWIN PHARMACEUTICAL CO., LIMITED
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Waston Medical Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. W. L. Gore & Associates, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Hangzhou Demo Medical Technology Co., Ltd
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BD.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Dolphin Sutures
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. gpcmedical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Golden Stapler Surgical Co., Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. JIANGSU JOYMED TECH CO., LTD
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Changzhou Haiers Medical Devices Co., Ltd
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Shanghai MedEco Industry Co., Ltd
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. ChangZhou WeiPu Medical Devices CO., LTD
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Anastomosis Device Market
  • Table 3: Anastomosis Device Market Analysis in Global (2021-2030)
  • Table 4: Anastomosis Device Market Analysis in Global by Product (2021-2030)
  • Table 5: Anastomosis Device Market Analysis in Global by Usability (2021-2030)
  • Table 6: Anastomosis Device Market Analysis in Global by Application (2021-2030)
  • Table 7: Anastomosis Device Market Analysis in Global by End-User (2021-2030)
  • Table 8: Anastomosis Device Market Analysis in Global by Geography (2021-2030)
  • Table 9: Anastomosis Device Market Analysis in North America (2021-2030)
  • Table 10: Anastomosis Device Market Analysis in North America by Country (2021-2030)
  • Table 11: Anastomosis Device Market Analysis in the US (2021-2030)
  • Table 12: Anastomosis Device Market Analysis in Canada (2021-2030)
  • Table 13: Anastomosis Device Market Analysis in Mexico (2021-2030)
  • Table 14: Anastomosis Device Market Analysis in Europe (2021-2030)
  • Table 15: Anastomosis Device Market Analysis in Europe by Country (2021-2030)
  • Table 16: Anastomosis Device Market Analysis in France (2021-2030)
  • Table 17: Anastomosis Device Market Analysis in Germany (2021-2030)
  • Table 18: Anastomosis Device Market Analysis in the UK (2021-2030)
  • Table 19: Anastomosis Device Market Analysis in Italy (2021-2030)
  • Table 20: Anastomosis Device Market Analysis in Spain (2021-2030)
  • Table 21: Anastomosis Device Market Analysis in the Rest of Europe (2021-2030)
  • Table 22: Anastomosis Device Market Analysis in Asia-Pacific (2021-2030)
  • Table 23: Anastomosis Device Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24: Anastomosis Device Market Analysis in China (2021-2030)
  • Table 25: Anastomosis Device Market Analysis in Japan (2021-2030)
  • Table 26: Anastomosis Device Market Analysis in India (2021-2030)
  • Table 27: Anastomosis Device Market Analysis in Australia (2021-2030)
  • Table 28: Anastomosis Device Market Analysis in South Korea (2021-2030)
  • Table 29: Anastomosis Device Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 30: Anastomosis Device Market Analysis in the Rest of the World (2021-2030)
  • Table 31: Anastomosis Device Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 32: Anastomosis Device Market Analysis in the Middle East (2021-2030)
  • Table 33: Anastomosis Device Market Analysis in Africa (2021-2030)
  • Table 34: Anastomosis Device Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Anastomosis Device Market
  • Figure 3: Anastomosis Device Market Analysis in Global (2021-2030)
  • Figure 4: Anastomosis Device Market Analysis in Global by Product (2021-2030)
  • Figure 5: Anastomosis Device Market Analysis in Global by Usability (2021-2030)
  • Figure 6: Anastomosis Device Market Analysis in Global by Application (2021-2030)
  • Figure 7: Anastomosis Device Market Analysis in Global by End-User (2021-2030)
  • Figure 8: Anastomosis Device Market Analysis in Global by Geography (2021-2030)
  • Figure 9: Anastomosis Device Market Analysis in North America (2021-2030)
  • Figure 10: Anastomosis Device Market Analysis in North America by Country (2021-2030)
  • Figure 11: Anastomosis Device Market Analysis in the US (2021-2030)
  • Figure 12: Anastomosis Device Market Analysis in Canada (2021-2030)
  • Figure 13: Anastomosis Device Market Analysis in Mexico (2021-2030)
  • Figure 14: Anastomosis Device Market Analysis in Europe (2021-2030)
  • Figure 15: Anastomosis Device Market Analysis in Europe by Country (2021-2030)
  • Figure 16: Anastomosis Device Market Analysis in France (2021-2030)
  • Figure 17: Anastomosis Device Market Analysis in Germany (2021-2030)
  • Figure 18: Anastomosis Device Market Analysis in the UK (2021-2030)
  • Figure 19: Anastomosis Device Market Analysis in Italy (2021-2030)
  • Figure 20: Anastomosis Device Market Analysis in Spain (2021-2030)
  • Figure 21: Anastomosis Device Market Analysis in the Rest of Europe (2021-2030)
  • Figure 22: Anastomosis Device Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23: Anastomosis Device Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24: Anastomosis Device Market Analysis in China (2021-2030)
  • Figure 25: Anastomosis Device Market Analysis in Japan (2021-2030)
  • Figure 26: Anastomosis Device Market Analysis in India (2021-2030)
  • Figure 27: Anastomosis Device Market Analysis in Australia (2021-2030)
  • Figure 28: Anastomosis Device Market Analysis in South Korea (2021-2030)
  • Figure 29: Anastomosis Device Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 30: Anastomosis Device Market Analysis in the Rest of the World (2021-2030)
  • Figure 31: Anastomosis Device Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 32: Anastomosis Device Market Analysis in the Middle East (2021-2030)
  • Figure 33: Anastomosis Device Market Analysis in Africa (2021-2030)
  • Figure 34: Anastomosis Device Market Analysis in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Market Opportunities
  • Figure 38: PORTER's Five Force Analysis